gastric cancer
Conditions
Interventions
Oral intake of oral nutrition (ENORAS 187.5ml/pack) will be started within 3 days of the start of postoperative meals and continued until postoperative day 90. The dosage may be increased or decreased
s subjective symptoms, etc., within the range of up to 3 packs/day (562.5 ml/day). The dosage may be increased or decreased at the discretion of the patient.
Sponsors
Niigata University
Niigata Cancer Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with histologically confirmed gastric cancer (2) Patients planned to undergo radical gastrectomy (3) Patients without distant metastasis (4) Patients aged between 20 and 80 years at the time of enrollment (5) Patients with a PS (ECOG) of 0 or 1 (6) Patients with preserved major organ function according to clinical examination within 14 days prior to enrollment (7) A patient whose written informed consent has been obtained
Exclusion criteria
Exclusion criteria: (1) Patients with carcinoma in the remnant stomach after gastrectomy (2) Patients with active multiple cancers (3) Patients with serious comorbidities (interstitial pneumonia or pulmonary fibrosis, difficult-to-control diabetes or hypertension, heart failure, renal failure, liver cirrhosis, liver failure, etc.) (4) Patients with allergies to oral nutritional supplements (5) Patients on warfarin medication (6) Patients with lactose intolerance (7) Patients with medical electrical devices such as pacemakers and implantable cardiac defibrillators (8) Patients with motor disorders of the upper or lower limbs due to orthopedic or neurological diseases, etc. (9) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients who took an average of 200 kcal/day or more of oral nutrition | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight loss rate, fat loss rate, and gluten loss rate 3 months after surgery Weight loss rate, fat-free weight loss rate, and gluten reduction rate 1 year after surgery Evaluation of various types of nutrition (TP, Alb, T-Chol, Rine pellet count, etc.) Adverse events | — |
Countries
Japan
Contacts
Public ContactHiroshi Ichikawa
Niigata University Graduate School of Medical and Dental Sciences Division of Digestive and General Surgery
Outcome results
None listed